NAFDAC Ensures Safety of US-Nigeria Medical Supplies

The National Agency for Food and Drug Administration and Control (NAFDAC) has confirmed that medicines and vaccines supplied to Nigeria under the US-Nigeria Government (USG-GoN) agreement will be rigorously tested for quality, safety, and efficacy. This initiative aims to fill gaps in HIV/AIDS medicine supply following the exit of the United States Agency for International Development (USAID).

NAFDAC will employ a technology-driven track-and-trace system to oversee the distribution of these medical products. The agency clarified that while products manufactured in the United States and approved by the US Food and Drug Administration (FDA) may benefit from expedited procedures, all other products will undergo thorough assessments.

NAFDAC's Director-General, Prof. Mojisola Christianah Adeyeye, emphasized the agency's commitment to ensuring that all medical products entering Nigeria meet required standards. The agency also recalled that all COVID-19 vaccines supplied during the pandemic were tested at its laboratory in Yaba, Lagos, despite WHO recognition of their safety.